Related Experiment Videos
Do patient self-help organizations help?
1Ankylosing Spondylitis International Federation, Michaeliburgstr. 15, D-81671, München, Germany.
Best Practice & Research. Clinical Rheumatology
|October 31, 2002
Summary
Ankylosing spondylitis patient organizations in 24 countries aid patients in disease management. Patients and healthcare professionals recognize the significant value of these organizations in coping with ankylosing spondylitis (AS).
Area of Science:
- Rheumatology
- Patient Advocacy
- Health Services Research
Background:
- Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine.
- Patient organizations play a crucial role in supporting individuals with chronic conditions.
- The global presence and impact of AS patient organizations are not fully elucidated.
Purpose of the Study:
- To describe the functions and contributions of ankylosing spondylitis patient organizations worldwide.
- To evaluate how patients with AS and healthcare professionals perceive the value of these organizations.
- To understand the support systems available for individuals managing ankylosing spondylitis.
Main Methods:
- A review of existing ankylosing spondylitis patient organizations across 24 countries.
- Qualitative and quantitative assessments of patient and health professional feedback on organizational contributions.
- Analysis of the role of patient advocacy in chronic disease management.
Main Results:
- Ankylosing spondylitis patient organizations are established in 24 countries, offering vital support.
- Patients and healthcare professionals report positive impacts on coping mechanisms and disease management.
- Contributions range from information dissemination to emotional support and community building.
Conclusions:
- Ankylosing spondylitis patient organizations provide essential support for patients navigating their disease.
- The collaborative efforts between patients and healthcare professionals highlight the importance of these organizations.
- Further research can explore optimizing the impact of patient advocacy groups in rheumatological care.